Gong et al. 2021 (PRJNA605444)
General Details
Title | Male-specific lymphomagenesis by serial inverse dysregulation of the RNA helicases DDX3X and DDX3Y. |
---|---|
Organism | |
Number of Samples | 20 |
Release Date | 2020/01/09 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP247659 |
---|---|
ENA | SRP247659 |
GEO | GSE143393 |
BioProject | PRJNA605444 |
Publication
Title | |
---|---|
Authors | Gong C,Krupka JA,Gao J,Grigoropoulos NF,Giotopoulos G,Asby R,Screen M,Usheva Z,Cucco F,Barrans S,Painter D,Zaini NBM,Haupl B,Bornelöv S,Ruiz De Los Mozos I,Meng W,Zhou P,Blain AE,Forde S,Matthews J,Khim Tan MG,Burke GAA,Sze SK,Beer P,Burton C,Campbell P,Rand V,Turner SD,Ule J,Roman E,Tooze R,Oellerich T,Huntly BJ,Turner M,Du MQ,Samarajiwa SA,Hodson DJ |
Journal | Molecular cell |
Publication Date | 2021 Oct 7 |
Abstract | DDX3X is a ubiquitously expressed RNA helicase involved in multiple stages of RNA biogenesis. DDX3X is frequently mutated in Burkitt lymphoma, but the functional basis for this is unknown. Here, we show that loss-of-function DDX3X mutations are also enriched in MYC-translocated diffuse large B cell lymphoma and reveal functional cooperation between mutant DDX3X and MYC. DDX3X promotes the translation of mRNA encoding components of the core translational machinery, thereby driving global protein synthesis. Loss-of-function DDX3X mutations moderate MYC-driven global protein synthesis, thereby buffering MYC-induced proteotoxic stress during early lymphomagenesis. Established lymphoma cells restore full protein synthetic capacity by aberrant expression of DDX3Y, a Y chromosome homolog, the expression of which is normally restricted to the testis. These findings show that DDX3X loss of function can buffer MYC-driven proteotoxic stress and highlight the capacity of male B cell lymphomas to then compensate for this loss by ectopic DDX3Y expression. Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. |
PMC | |
PMID | 34437837 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR11041329 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041330 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041300 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041301 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041302 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041303 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041304 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041305 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041306 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041307 | PRJNA605444 | Homo sapiens | Mutu | Ribo-Seq | |||||||||
SRR11041319 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041320 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041321 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041322 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041323 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041324 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041325 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041326 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041327 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
SRR11041328 | PRJNA605444 | Homo sapiens | U2OS | Ribo-Seq | |||||||||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About